Extended-spectrum β-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system

Journal of Medical Microbiology

Volumn 60, Issue 6, 2011, Pages 756-760

  Espinar, Maria Jose ^a,b   Rocha, Rita ^b   Ribeiro, Manuela ^a   Rodrigues, Acácio Gonçalves ^a,b   Pina Vaz, Cidalia ^a,b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; FALSE POSITIVE RESULT; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; AUTOMATION; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CROSS INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS;

EID: 79957590706     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.024075-0     Document Type: Article

References (18)

1. Bell, J. M., Chitsaz, M., Turnidge, J. D., Barton, M., Walters, L. J. & Jones, R. N. (2007). Prevalence and significance of a negative extended-spectrum β-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program. J Clin Microbiol 45, 1478-1482.
2. Bradford, P. A. (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14, 933-951.
3. Canton, R., Oliver, A., Coque, T. M., Varela, M del C., Perez-Diaz, J. C. & Baquero, F. (2002). Epidemiology of extended-spectrum β-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. J Clin Microbiol 40, 1237-1243.
4. CLSI (2010). Performance Standards for Antimicrobial Susceptibility Testing; 20th Informational Supplement. M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute.
5. Dashti, A. A., Jadaon, M. M. & Habeeb, F. M. (2009). Can we rely on one laboratory test in detection of extended-spectrum β-lactamases among Enterobacteriaceae? An evaluation of the Vitek 2 system and comparison with four other detection methods in Kuwait. J Clin Pathol 62, 739-742.
6. Fang, H., Ataker, F., Hedin, G. & Dornbusch, K. (2008). Molecular epidemiology of extended-spectrum β-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol 46, 707-712.
7. Hoffman, C. S. & Winston, F. (1987). A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57, 267-272.
8. Jacoby, G. A. & Sutton, L. (1991). Properties of plasmids responsible for production of extended-spectrum β-lactamases. Antimicrob Agents Chemother 35, 164-169.
9. Kaye, K.S., Engemann, J.J., Fraimow, H.S. & Abrutyn, E. (2004). Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am 18, 467-511, 8.
10. Livermore, D. M. (1995). β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8, 557-584.
11. Mendonca, N., Ferreira, E., Louro, D., ARSIP Participants & Canica, M. (2009). Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum β-lactamase-producing Klebsiella pneumoniae isolated in Portugal. Int J Antimicrob Agents 34, 29-37.
12. Paterson, D. L. & Bonomo, R. A. (2005). Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 18, 657-686.
13. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Extraction and purification of plasmid DNA. In Molecular Cloning: a Laboratory Manual, 2nd edn, pp. 1.21-1.43. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
14. Spanu, T., Sanguinetti, M., Tumbarello, M., D'Inzeo, T., Fiori, B., Posteraro, B., Santangelo, R., Cauda, R. & Fadda, G. (2006). Evaluation of the new VITEK 2 extended-spectrum β-lactamase (ESBL) test for rapid detection of ESBL production in Entero-bacteriaceae isolates. J Clin Microbiol 44, 3257-3262.
15. Sturenburg, E., Sobottka, I., Feucht, H. H., Mack, D. & Laufs, R. (2003). Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum β-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. Diagn Microbiol Infect Dis 45, 29-34.
16. Tamayo, J., Orden, B., Cacho, J., Cuadros, J., Gomez-Garces, J. L. & Alos, J. I. (2007). Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid. Rev Esp Quimioter 20, 334-338.
17. Thomson, K. S., Cornish, N. E., Hong, S. G., Hemrick, K., Herdt, C. & Moland, E. S. (2007). Comparison of Phoenix and VITEK 2 extended-spectrum-β-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized β-lactamases. J Clin Microbiol 45, 2380-2384.
18. Wiegand, I., Geiss, H. K., Mack, D., Sturenburg, E. & Seifert, H. (2007). Detection of extended-spectrum β-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J Clin Microbiol 45, 1167-1174.